Prosecution Insights
Last updated: October 27, 2026
Application No. 18/394,637

LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME

Non-Final OA §102
Filed
Dec 22, 2023
Priority
Jan 03, 2023 — RE 10-2023-0000738
Examiner
NGUYEN, VU ANH
Art Unit
Tech Center
Assignee
Samsung Display Co., Ltd.
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
1275 granted / 1531 resolved
+23.3% vs TC avg
Strong +16% interview lift
Without
With
+15.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
27 currently pending
Career history
1559
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
40.3%
+0.3% vs TC avg
§102
27.8%
-12.2% vs TC avg
§112
27.8%
-12.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1531 resolved cases

Office Action

§102
Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-8 and 12-21 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by CN 113461627 A1 to Zhang et al. (see attached machine-generated English-language translation). Regarding claim 1, Zhang et al. discloses an OLED wherein the EML comprises a host material typified by the following compound: PNG media_image1.png 166 220 media_image1.png Greyscale . This compound is representative of the claimed compound wherein Ar1 = biphenyl substituted with diphenyltriazinyl, L1 = direct bond, L2 = phenylene, Ar2 = phenyl and Ar3 = H. Note that the term “substituted” in claim 1 is defined in the specification (paragraph [0045]) as including an aryl group that may be further substituted. Claim 1 is therefore unpatentable for being anticipated. See MPEP § 2131.02(II). So are claims 2-4 and 7-8. The compound is representative of formula 4-1 in claim 5 wherein R11 is a substituted aryl group. It also reads on formula 5-2 of claim 6. Claims 12-21 are unpatentable for the same reasons. Claims 1-23 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 2019/0039996 A1 to Takada et al. Regarding claim 1, Takada et al. discloses an OLED wherein the hole transport layer comprises a triarylamine typified by the following compound on page 8: PNG media_image2.png 384 472 media_image2.png Greyscale . This compound is representative of the claimed compound wherein Ar1 = aryl, L1 = phenylene, L2 = direct bond, Ar2 = phenyl, R1 = Ar3 = H, two adjacent R2 combined to form a ring. Claim 1 is therefore unpatentable for being anticipated. So are claims 2-22. The compound is identical to compound DH10 in claim 23. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to VU ANH NGUYEN whose telephone number is (571)270-5454. The examiner can normally be reached M-F 8:00 AM-5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, ROBERT JONES can be reached at (571) 270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /VU A NGUYEN/Primary Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Dec 22, 2023
Application Filed
Oct 09, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12767648
COMPOUND FOR ORGANIC OPTOELECTRONIC ELEMENT, COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE
3y 11m to grant Granted Oct 20, 2026
Patent 12765553
COMPOSITIONS AND METHODS FOR ANTIMICROBIAL ARTICLES
3y 11m to grant Granted Oct 20, 2026
Patent 12760006
HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE
4y 7m to grant Granted Oct 13, 2026
Patent 12765258
ORGANIC ELECTROLUMINESCENT DEVICE
4y 0m to grant Granted Oct 13, 2026
Patent 12757628
LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE SAME, AND THE HETEROCYCLIC COMPOUND
3y 7m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
99%
With Interview (+15.8%)
2y 5m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1531 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month